SMAD2 and breast carcinoma: In breast cancer cells, TGFβ levels as well as the downstream expression of NRP1 and SMAD-2 are negatively regulated by microRNA (miR)-206, and overexpression of miR-206 inhibits EMT as well as migration and invasion of breast cancer cells [205].